Netflix, Inc. (LON:0QYI)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	371,672	304,333	167,299	108,912	197,076	174,974
Market Cap Growth	80.77%	81.91%	53.61%	-44.74%	12.63%	63.42%
Enterprise Value	378,122	311,749	174,283	117,476	204,815	182,111
Last Close Price	874.05	722.09	385.08	238.44	452.42	385.41
PE Ratio	49.69	43.74	39.40	29.21	52.16	86.51
PS Ratio	12.21	9.77	6.32	4.15	8.99	9.56
PB Ratio	20.41	15.40	10.35	6.32	16.84	21.59
P/TBV Ratio	40.16	30.92	27.09	16.31	130.17	-
P/FCF Ratio	-	55.04	30.77	81.08	-	123.83
P/OCF Ratio	-	51.76	29.30	64.76	679.69	98.43
EV/Sales Ratio	12.01	10.01	6.58	4.48	9.34	9.95
EV/EBITDA Ratio	37.65	36.32	30.37	23.71	43.31	52.89
EV/EBIT Ratio	40.71	37.46	31.92	25.13	44.77	54.23
EV/FCF Ratio	60.94	56.39	32.05	87.45	-	128.88
Debt / Equity Ratio	0.68	0.73	0.82	0.82	1.14	1.67
Debt / EBITDA Ratio	1.27	1.58	2.14	2.57	2.61	3.60
Debt / FCF Ratio	1.99	2.60	2.45	10.46	-	9.60
Asset Turnover	0.82	0.76	0.69	0.68	0.71	0.68
Quick Ratio	1.12	1.08	1.01	0.96	0.81	1.13
Current Ratio	1.34	1.22	1.12	1.17	0.95	1.25
Return on Equity (ROE)	43.55%	38.44%	26.15%	24.53%	38.02%	29.62%
Return on Assets (ROA)	15.05%	12.72%	8.93%	7.56%	9.23%	7.82%
Return on Capital (ROIC)	19.10%	16.22%	11.55%	9.82%	12.19%	10.71%
Return on Capital Employed (ROCE)	27.90%	24.30%	17.40%	13.90%	17.20%	14.60%
Earnings Yield	2.01%	2.29%	2.54%	3.42%	1.92%	1.16%
FCF Yield	1.67%	1.82%	3.25%	1.23%	-0.05%	0.81%
Buyback Yield / Dilution	1.57%	2.28%	0.40%	0.90%	-0.26%	-0.54%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.